Screening
NAFLD, cirrhosis
CIRRHOSIS
Patients in the NAFLD and cirrhosis group were consecutively recruited in the outpatient clinic at the Gastro‐Unit, Hvidovre Hospital, if found eligible for diagnostic transjugular liver biopsy by their treating physician. Healthy subjects were recruited through self‐referral by advertising. The screening visit included an interview, informed consent, transient elastography measurement (FibroScan®, Echosens), blood tests (complete blood count, liver function tests, basic metabolic tests, and cholesterol), as well as anthropometric measurements, including waist circumference and bioimpedance measurement (SECA electronics) with visceral adipose tissue (VAT) measurement. Transient elastography was performed by a trained physician and required at least ten valid measurements with an IQR <30%. All participants were fasting for at least 4 h before the measurement, and M or XL probes were used as appropriate.